• SIBO Symposium: Underlying Causes, all presentations

    Original Date: March 16-17, 2019

    This discounted package includes all of the individual presentations from the conference, which are listed below.

    12.75 CEUs (1.0 pharmacy and 11.75 general) approved by OBNM
  • This course requires an enrollment key
    Cost: US$ 55.00
    SIBO Overview

    Presenter: Lisa Shaver, ND, LAc
    Original Date: March 16, 2019

    In this overview of Small Intestinal Bacterial Overgrowth Dr. Shaver outlines the various signs and symptoms, their causes as well as the underlying causes of SIBO. The breath and serum testing options are discussed as well as the analyses thereof. Treatment option include pharmaceuticals such as rifaximin, metronidazole and neomycin, as well as antibiotics which do not seem to fully address SIBO such as amoxicillin, and ciprofloxacin. The many herbal antibiotics are reviewed as will be the elemental diet, with attention to when to prescribe such antifungals as nystatin and fluconazole, or herbal equivalents. When to use prokinetics such as prucalopride, erythromycin and naltrexone will is also discussed. Foods that play a role and various diets are reviewed. There are various associated diseases and syndromes linked to SIBO as well as obstacles to successful treatment and when to prescribe medications such as nitazoxanide, tinidazole, albendazole, mebendazole, metronidazole.

    1.5 CEUs (0.5 pharmacy and 1.0 general) approved by OBNM
  • Underlying Causes of SIBO

    Presenter: Allison Siebecker, ND, LAc
    Original Date: March 16, 2019

    There are many causes of Small Intestine Bacterial Overgrowth. This lecture explains both the physiologic underlying causes as well as the many risk factors. Physiologic underlying causes primarily encompass failure of protective mechanisms such as the migrating motor complex and anatomic alterations. Risk factors encompass diseases, injuries (including surgery), medications and other lifestyle factors as well as genetics. A clinical checklist of risk factors is discussed along with testing and treatment.

    1.75 general CEUs approved by OBNM
  • Motility Disorders Associated with SIBO

    Presenter: Ali Rezaie, MD
    Original Date: March 16, 2019

    This presentation covers underlying motility disorders associated with SIBO such as abnormal MMCs, CIPO, enterocele, and bowel surgeries.

    1.5 general CEUs approved by OBNM
  • This course requires an enrollment key
    Cost: US$ 55.00
    Autoimmunity & SIBO

    Presenter: Mark Pimentel, MD
    Original Date: March 16, 2019

    SIBO is a common condition and with great overlap between SIBO and IBS. In fact, SIBO may be the cause of IBS in up to 70% of cases. We also know that food poisoning (acute gastroenteritis) can be a trigger for IBS/SIBO but the mechanisms for this have been unknown. Recent data suggest that food poisoning creates an autoantibody that can cause IBS and SIBO based on animal and human studies.

    This presentation explores the data around how autoimmunity is triggered after food poisoning and in the development of IBS and SIBO. We will also explore how this could change the prognosis of IBS and SIBO.

    Pharmaceutical agents discussed include rifaximin and neomycin. There is also discussion of prokinetics such as prucalopride and erythromycin.

    1.5 CEUs (0.5 pharmacy and 1.0 general) approved by OBNM
  • This course requires an enrollment key
    Cost: US$ 20.00
    Panel Discussion

    Presenter: Mark Pimentel, MD; Ali Rezaie, MD; and Allison Siebecker, ND, LAc
    Original Date: March 16, 2019


    0.5 general CEUs approved by OBNM
  • Parkinson's and the Gut Brain Axis

    Presenter: Heather Zwickey, PhD
    Original Date: March 17, 2019

    Parkinson’s disease has long been considered a neurological disorder. Yet, people with Parkinson’s exhibit both motor and non-motor symptoms, only some of which are brain derived. As we learn more and more about Parkinson’s, the gastrointestinal influences on disease is becoming increasingly clear. Not only do people with Parkinson’s experience constipation, there’s evidence that Parkinson’s may originate in the gut.

    In this seminar, we examine the gut-brain axis in Parkinson’s. We discuss microbiome influences on Parkinson’s, gut contributions to neuroinflammation, and strategies to balance the gut-axis in Parkinson’s disease.

    1.5 general CEUs approved by OBNM
  • Exploring the Relationship Between TBI and SIBO

    Presenter: Kayle Sandberg-Lewis, LMT, MA, BCN Fellow and Steven Sandberg-Lewis, ND, DHANP
    Original Date: March 17, 2019

    Parkinson’s disease has long been considered a neurological disorder. Yet, people with Parkinson’s exhibit both motor and non-motor symptoms, only some of which are brain derived. As we learn more and more about Parkinson’s, the gastrointestinal influences on disease is becoming increasingly clear. Not only do people with Parkinson’s experience constipation, there’s evidence that Parkinson’s may originate in the gut.

    In this seminar, we examine the gut-brain axis in Parkinson’s. We discuss microbiome influences on Parkinson’s, gut contributions to neuroinflammation, and strategies to balance the gut-axis in Parkinson’s disease.

    1.5 general CEUs approved by OBNM
  • Bariatric Surgery & SIBO

    Presenter: Jacqueline Jacques, ND
    Original Date: March 17, 2019

    Surgery for the treatment of obesity (bariatric surgery) was started in the United States in the 1950s and has evolved to include multiple procedures and devices over the past 60+ years. The earliest procedures, while effective for their primary goal, became infamous for creating severe malnutrition and toxic overgrowth of bacteria in the bypassed part of the small intestine. This bacteria proved so toxic in some patients that it led to liver failure and death.

    While that procedure was abandoned, others have replaced it including gastric bypass, duodenal switch, sleeve gastrectomy, and the mini bypass (omega loop). While none has proven to be as toxic as the original surgery, we have learned a lot along the way about how various surgical alternations to the gut can alter not only anatomy, but create changes in the microbiome that impact nutrition, metabolism, weight loss, and other aspects of physiology. This knowledge can help inform clinicians who are supporting surgical weight loss patients, and can also teach us some valuable lessons that apply to SIBO in non-surgical patients.

    1.5 general CEUs approved by OBNM
  • The IBS within IBD and Comparison for Laboratory Testing for the Functional GI Case

    Presenter: Ilana Gurevich, ND
    Original Date: March 17, 2019

    This 2-part presentation covers the way that IBD and IBS interact and the underlying causes of IBS that present in IBD and why. The first part of the presentation looks in depth at SIBO, fistula’s, fissures, and bacterial changes of the GI. Part 2 is a look at a majority of functional GI testing and if there is any scientific validity to those tests.

    1.5 general CEUs approved by OBNM

Privacy Policy